Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

July 01, 1987; Volume 32,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ahlijanian, M K

    1. You have access
      Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.
      M K Ahlijanian and D M Cooper
      Molecular Pharmacology July 1987, 32 (1) 127-132;
  2. Aiyar, N

    1. You have access
      Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;
  3. Akera, T

    1. You have access
      Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;
    2. You have access
      Relative abundance of two molecular forms of Na+,K+-ATPase in the ferret heart: developmental changes and associated alterations of digitalis sensitivity.
      Y C Ng and T Akera
      Molecular Pharmacology August 1987, 32 (1) 201-205;

B

  1. Balzarini, J

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
  2. Bao, Z P

    1. You have access
      Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
      S K Yang and Z P Bao
      Molecular Pharmacology July 1987, 32 (1) 73-80;
  3. Belinsky, S A

    1. You have access
      Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;
  4. Bentrude, W G

    1. You have access
      Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
      E De Clercq, J Bères and W G Bentrude
      Molecular Pharmacology August 1987, 32 (1) 286-292;
  5. Benz, C

    1. You have access
      Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.
      C Benz and G F Santos
      Molecular Pharmacology July 1987, 32 (1) 13-16;
  6. Bères, J

    1. You have access
      Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
      E De Clercq, J Bères and W G Bentrude
      Molecular Pharmacology August 1987, 32 (1) 286-292;
  7. Berger, K D

    1. You have access
      The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
      R D Brown, K D Berger and P Taylor
      Molecular Pharmacology July 1987, 32 (1) 43-52;
  8. Birkett, D J

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;
  9. Blank, J A

    1. You have access
      alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;
  10. Bock, K W

    1. You have access
      Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;
  11. Bornheim, L M

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;
  12. Braswell, L M

    1. You have access
      Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
      B A Dodson, L M Braswell and K W Miller
      Molecular Pharmacology July 1987, 32 (1) 119-126;
  13. Brennan, J

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;
  14. Broder, S

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
  15. Brown, R D

    1. You have access
      The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
      R D Brown, K D Berger and P Taylor
      Molecular Pharmacology July 1987, 32 (1) 43-52;
  16. Burgess, W

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

C

  1. Caldera, P

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;
  2. Candelore, M R

    1. You have access
      Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;
  3. Christophe, J

    1. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
      M Gillard, M Waelbroeck and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 100-108;
    2. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;
  4. Colucci, W S

    1. You have access
      Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
      G Sperti and W S Colucci
      Molecular Pharmacology July 1987, 32 (1) 37-42;
  5. Convents, A

    1. You have access
      Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;
  6. Convents, D

    1. You have access
      Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;
  7. Cooper, D M

    1. You have access
      Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.
      M K Ahlijanian and D M Cooper
      Molecular Pharmacology July 1987, 32 (1) 127-132;
    2. You have access
      Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
      E Perez-Reyes and D M Cooper
      Molecular Pharmacology August 1987, 32 (1) 212-216;
  8. Correia, M A

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;
  9. Coughlin, R T

    1. You have access
      Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;
  10. Crooke, S T

    1. You have access
      Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;
    2. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
    3. You have access
      SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;
    4. You have access
      Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;

D

  1. Dalal, M

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
  2. De Backer, J P

    1. You have access
      Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;
  3. De Clercq, E

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
    2. You have access
      Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
      E De Clercq, J Bères and W G Bentrude
      Molecular Pharmacology August 1987, 32 (1) 286-292;
  4. Dehmel, V C

    1. You have access
      Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
      R J Schimmel, M E Elliott and V C Dehmel
      Molecular Pharmacology July 1987, 32 (1) 26-33;
  5. De Souza, N J

    1. You have access
      Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;
  6. DeWolf, W E

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
  7. Diamond, J

    1. You have access
      Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;
  8. Dixon, R A

    1. You have access
      Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;
  9. Dodson, B A

    1. You have access
      Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
      B A Dodson, L M Braswell and K W Miller
      Molecular Pharmacology July 1987, 32 (1) 119-126;
  10. Drake, F H

    1. You have access
      Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

E

  1. Elliott, M E

    1. You have access
      Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
      R J Schimmel, M E Elliott and V C Dehmel
      Molecular Pharmacology July 1987, 32 (1) 26-33;

F

  1. Fisher, S K

    1. You have access
      Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
      S K Fisher and R M Snider
      Molecular Pharmacology July 1987, 32 (1) 81-90;

G

  1. Galper, J B

    1. You have access
      Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;
  2. Gasiewicz, T A

    1. You have access
      alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;
  3. Gillard, M

    1. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
      M Gillard, M Waelbroeck and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 100-108;
    2. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;
  4. Gleason, J G

    1. You have access
      SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;
  5. Gotlib, L

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

H

  1. Hagiwara, M

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;
  2. Haigh, L S

    1. You have access
      Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;
  3. Hall, P D

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;
  4. Hall, R F

    1. You have access
      SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;
  5. Hantelle, P

    1. You have access
      Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;
  6. Harbon, S

    1. You have access
      Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
      Z Tanfin and S Harbon
      Molecular Pharmacology August 1987, 32 (1) 249-257;
  7. Harris, K H

    1. You have access
      Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;
  8. Hart, A C

    1. You have access
      Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;
  9. Herdewijn, P

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
  10. Hidaka, H

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;
  11. Hoffman, P L

    1. You have access
      Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
      P Valverius, P L Hoffman and B Tabakoff
      Molecular Pharmacology August 1987, 32 (1) 217-222;
  12. Howard, M J

    1. You have access
      Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
    2. You have access
      Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;
  13. Hughes, R J

    1. You have access
      Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

I

  1. Inagaki, M

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;
  2. Insel, P A

    1. You have access
      Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
    2. You have access
      Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;
  3. Ito, M

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

J

  1. Jacobson, K A

    1. You have access
      A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
      G L Stiles and K A Jacobson
      Molecular Pharmacology August 1987, 32 (1) 184-188;
  2. Johns, D G

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
  3. Johnson, R K

    1. You have access
      Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

K

  1. Kamp, T J

    1. You have access
      Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles.
      T J Kamp and R J Miller
      Molecular Pharmacology August 1987, 32 (1) 278-285;
  2. Kang, G J

    1. You have access
      The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
  3. Kari, F W

    1. You have access
      Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;
  4. Katoh, A

    1. You have access
      Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
      T Nakajima and A Katoh
      Molecular Pharmacology July 1987, 32 (1) 140-146;
  5. Kauffman, F C

    1. You have access
      Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;
  6. Kazmi, S M

    1. You have access
      Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
      S M Kazmi and R K Mishra
      Molecular Pharmacology July 1987, 32 (1) 109-118;
  7. Kelley, M

    1. You have access
      Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;
  8. Khandelwal, Y

    1. You have access
      Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;
  9. Kruse, L I

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

L

  1. Laurenza, A

    1. You have access
      Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;
  2. Laychock, S G

    1. You have access
      Alpha 2-adrenoceptor stimulation affects total glucose utilization in isolated islets of Langerhans.
      S G Laychock
      Molecular Pharmacology August 1987, 32 (1) 241-248;
  3. Levin, W

    1. You have access
      Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;
  4. Lilienblum, W

    1. You have access
      Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;
  5. Livingston, D J

    1. You have access
      Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;
  6. Lönn, S

    1. You have access
      Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
      U Lönn and S Lönn
      Molecular Pharmacology July 1987, 32 (1) 154-161;
  7. Lönn, U

    1. You have access
      Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
      U Lönn and S Lönn
      Molecular Pharmacology July 1987, 32 (1) 154-161;
  8. Luster, M I

    1. You have access
      alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

M

  1. MacLeod, K M

    1. You have access
      Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;
  2. Makar, A B

    1. You have access
      The role of formate and S-adenosylmethionine in the reversal of nitrous oxide inhibition of formate oxidation in the rat.
      A B Makar and T R Tephly
      Molecular Pharmacology August 1987, 32 (1) 309-314;
  3. Manning, D R

    1. You have access
      Structural characteristics of the 35- and 36-kDa forms of the beta subunit common to GTP-binding regulatory proteins.
      M J Woolkalis and D R Manning
      Molecular Pharmacology July 1987, 32 (1) 1-6;
  4. Mattern, M R

    1. You have access
      Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;
  5. McGroarty, E J

    1. You have access
      Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;
  6. McKernan, R M

    1. You have access
      Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
  7. McManus, M E

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;
  8. Metzger, H

    1. You have access
      Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;
  9. Miller, J

    1. You have access
      SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;
  10. Miller, K W

    1. You have access
      Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
      B A Dodson, L M Braswell and K W Miller
      Molecular Pharmacology July 1987, 32 (1) 119-126;
  11. Miller, R J

    1. You have access
      Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles.
      T J Kamp and R J Miller
      Molecular Pharmacology August 1987, 32 (1) 278-285;
  12. Minnich, M D

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
  13. Mirabelli, C K

    1. You have access
      Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;
  14. Mishra, R K

    1. You have access
      Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
      S M Kazmi and R K Mishra
      Molecular Pharmacology July 1987, 32 (1) 109-118;
  15. Mong, S

    1. You have access
      SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;
  16. Motulsky, H J

    1. You have access
      Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
    2. You have access
      Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;
  17. Mullen, M D

    1. You have access
      Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

N

  1. Nakajima, T

    1. You have access
      Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
      T Nakajima and A Katoh
      Molecular Pharmacology July 1987, 32 (1) 140-146;
  2. Nambi, P

    1. You have access
      Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;
  3. Ng, D D

    1. You have access
      Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;
  4. Ng, Y C

    1. You have access
      Relative abundance of two molecular forms of Na+,K+-ATPase in the ferret heart: developmental changes and associated alterations of digitalis sensitivity.
      Y C Ng and T Akera
      Molecular Pharmacology August 1987, 32 (1) 201-205;

O

  1. O'Hara, D S

    1. You have access
      Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;
  2. Oesch, F

    1. You have access
      Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;
  3. Olsen, R W

    1. You have access
      gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
      J S Yang and R W Olsen
      Molecular Pharmacology August 1987, 32 (1) 266-277;
  4. Onoda, K

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

P

  1. Per, S R

    1. You have access
      Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;
  2. Perez-Reyes, E

    1. You have access
      Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
      E Perez-Reyes and D M Cooper
      Molecular Pharmacology August 1987, 32 (1) 212-216;
  3. Platt, K L

    1. You have access
      Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;

R

  1. Rands, E

    1. You have access
      Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;
  2. Rettie, A E

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;
  3. Robberecht, P

    1. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;
  4. Robson, R

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;
  5. Rupp, R H

    1. You have access
      Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

S

  1. Safe, S

    1. You have access
      Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;
  2. Santos, G F

    1. You have access
      Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.
      C Benz and G F Santos
      Molecular Pharmacology July 1987, 32 (1) 13-16;
  3. Schaeffer, V H

    1. You have access
      Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles.
      V H Schaeffer and J L Stevens
      Molecular Pharmacology August 1987, 32 (1) 293-298;
  4. Schimmel, R J

    1. You have access
      Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
      R J Schimmel, M E Elliott and V C Dehmel
      Molecular Pharmacology July 1987, 32 (1) 26-33;
  5. Schirmer, G

    1. You have access
      Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;
  6. Seamon, K B

    1. You have access
      Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;
  7. Shorr, R G

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
  8. Snider, R M

    1. You have access
      Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
      S K Fisher and R M Snider
      Molecular Pharmacology July 1987, 32 (1) 81-90;
  9. Sperti, G

    1. You have access
      Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
      G Sperti and W S Colucci
      Molecular Pharmacology July 1987, 32 (1) 37-42;
  10. Stassen, F

    1. You have access
      Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;
  11. Steinbach, C

    1. You have access
      Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;
  12. Stevens, J L

    1. You have access
      Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles.
      V H Schaeffer and J L Stevens
      Molecular Pharmacology August 1987, 32 (1) 293-298;
  13. Stiles, G L

    1. You have access
      A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
      G L Stiles and K A Jacobson
      Molecular Pharmacology August 1987, 32 (1) 184-188;
  14. Strader, C D

    1. You have access
      Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;
  15. Strohsacker, M W

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
  16. Stupans, I

    1. You have access
      Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;
  17. Sweatlock, J

    1. You have access
      alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

T

  1. Tabakoff, B

    1. You have access
      Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
      P Valverius, P L Hoffman and B Tabakoff
      Molecular Pharmacology August 1987, 32 (1) 217-222;
  2. Tanaka, T

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;
  3. Tanfin, Z

    1. You have access
      Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
      Z Tanfin and S Harbon
      Molecular Pharmacology August 1987, 32 (1) 249-257;
  4. Taylor, P

    1. You have access
      The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
      R D Brown, K D Berger and P Taylor
      Molecular Pharmacology July 1987, 32 (1) 43-52;
  5. Tephly, T R

    1. You have access
      The role of formate and S-adenosylmethionine in the reversal of nitrous oxide inhibition of formate oxidation in the rat.
      A B Makar and T R Tephly
      Molecular Pharmacology August 1987, 32 (1) 309-314;
  6. Thomas, P E

    1. You have access
      Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;
  7. Thurman, R G

    1. You have access
      Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;
  8. Trager, W F

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;
  9. Tucker, A N

    1. You have access
      alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

U

  1. Underwood, M C

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

V

  1. Valverius, P

    1. You have access
      Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
      P Valverius, P L Hoffman and B Tabakoff
      Molecular Pharmacology August 1987, 32 (1) 217-222;
  2. Varrichio, A

    1. You have access
      Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
  3. Vauquelin, G

    1. You have access
      Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;

W

  1. Waelbroeck, M

    1. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
      M Gillard, M Waelbroeck and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 100-108;
    2. You have access
      Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;
  2. Watanabe, M

    1. You have access
      Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;
  3. Woolkalis, M J

    1. You have access
      Structural characteristics of the 35- and 36-kDa forms of the beta subunit common to GTP-binding regulatory proteins.
      M J Woolkalis and D R Manning
      Molecular Pharmacology July 1987, 32 (1) 1-6;
  4. Wrighton, S A

    1. You have access
      Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;
  5. Wu, H L

    1. You have access
      SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;

Y

  1. Yang, J S

    1. You have access
      gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
      J S Yang and R W Olsen
      Molecular Pharmacology August 1987, 32 (1) 266-277;
  2. Yang, S K

    1. You have access
      Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
      S K Yang and Z P Bao
      Molecular Pharmacology July 1987, 32 (1) 73-80;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 32, Issue 1
1 Jul 1987
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Wnt Signaling and Drug Resistance in Cancer
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics